Outcome of conservative therapy of patients with severe intermittent claudication

European Journal of Vascular and Endovascular Surgery

Volumn 27, Issue 3, 2004, Pages 254-258

  Amighi, J ^a   Sabeti, S ^a   Schlager, O ^a   Francesconi, M ^a   Ahmadi, R ^a   Minar, E ^a   Schillinger, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Conservative; Intermittent claudication; Medical; Progression

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHENPROCOUMON;

ADULT; AGED; AMPUTATION; ARTERY DISEASE; ARTICLE; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DETERIORATION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENDER; GENERAL CONDITION IMPROVEMENT; HEMODYNAMICS; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; REVASCULARIZATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; WALKING;

EID: 1442305463     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2003.12.005     Document Type: Article

References (35)

1. Hirsch AR, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-1324.
2. Williams LR, Ekers MA, Collins PS, Lee JF. Vascular rehabilitation: benefits of a structured exercise/risk modification program. J Vasc Surg 1991;14:320-326.
3. Izquierdo-Porrera AM, Gardner AW, Powell CC, Katzel LI. Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease. J Vasc Surg 2000;31:670-677.
4. Fowkes FG, Gillespie IN. Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database Syst Rev 2000;(2):CD000017.
5. Laxdal E, Jenssen GL, Pedersen G, Aune S. Subintimal angioplasty as a treatment of femoropopliteal artery occlusions. Eur J Vasc Endovasc Surg 2003;25:578-582.
6. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 2000;31:S1-S296.
7. Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, Ruckley CV. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg 1996;12:167-172.
8. Wagner HJ, Schmitz R, Alfke H, Klose KJ. Influence of percutaneous transluminal angioplasty on transcutaneous pressure in patients with peripheral arterial occlusive disease. Radiology 2003;226:791-797.
9. Chong PF, Golledge J, Greenhalgh RM, Davies AH. Exercise therapy or angioplasty? A summation analysis. Eur J Vasc Endovasc Surg 2000;20:4-12.
10. Belli AM, Cumberland DC, Knox AM, Procter AE, Welsh CL. The complication rate of percutaneous peripheral balloon angioplasty. Clin Radiol 1990;41:380-383.
11. Schillinger M, Mlekusch W, Haumer M, Sabeti S, Ahmadi R, Minar E. One year follow up after percutaneous transluminal angioplasty and elective stent implantation in de-novo versus recurrent femoropopliteal lesions. J Endovasc Ther 2003;10: 288-297.
12. Gray BH, Sullivan TM, Childs MB, Young Jr, Olin JW. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997;25:74-83.
13. Whitehill TA. Role of revascularization in the treatment of claudication. Vasc Med 1997;2:252-256.
14. Whyman MR, Ruckley CV. Should claudicants receive angioplasty or just exercise training? Cardiovasc Surg 1998;6:226-231.
15. Gutteridge W, Torrie EP, Galland RB. Cumulative risk of bypass, amputation or death following percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg 1997;14:134-139.
16. Degischer S, Labs KH, Hochstrasser J, Aschwanden M, Tschoepl M, Jaeger KA. Physical training for intermittent claudication: a comparison of structured rehabilitation versus home-based training. Vasc Med 2002;7:109-115.
17. Perkins JM, Collins J, Creasy TS, Fletcher EW, Morris PJ. Exercise training versus angioplasty for stable claudication, long and medium-term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg 1996;11:409-413.
18. Skinner JS, Strandness DE. Exercise and intermittent claudication, II. Effect of physical training. Circulation 1967;36:23-29.
19. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995;274:975-980.
20. Regensteiner JG, Steiner JF, Hiatt WG. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996;23:104-115.
21. Robeer GG, Brandsma JW, van den Heuwel SP, Smit B, Oostendorp RA, Wittens CH. Exercise therapy for intermittent claudication: a review of the quality of randomised clinical trials and evaluation of predictive factors. Eur J Vasc Endovasc Surg 1998;15:36-43.
22. Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2000;(2):CD000990.
23. Walker RD, Nawaz S, Wilkinson CH, Saxton JM, Pockley AG, Wood RF. Influence of upper-and lower limb exercise training on cardiovascular function and walking distance in patients with intermittent claudication. J Vasc Surg 2000;3:662-669.
24. Burns P, Lima E, Bradbury AW. What constitutes best medical therapy for peripheral arterial disease. Eur J Vasc Endovasc Surg 2002;24:6-12.
25. Price JF, Leng GC, Fowkes FGR. Should claudicants receive angioplasty or exercise training? Cardiovasc Surg 1997;5:463-470.
26. Whyman MR, Fowkes FGR, Kerracher EMG, Gillespie IN, Lee AJ, Housley E, Ruckley CV. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomised controlled trial. J Vasc Surg 1997;26:551-557.
27. Burns F, Gough S, Bradbury AW. Management of peripheral arterial disease in primary care. BMJ 2003;326:584-588.
28. Cox GS, Hertzer NR, Young JR, O'Hara PJ, Krajewski LP, Piedmonte MR, Beven EB. Non-operative treatment of superficial femoral artery disease: long-term follow-up. J Vasc Surg 1993;17:172-182.
29. De Felice M, Gallo P, Masotti G. Current therapy of peripheral obstructive arterial disease. The non-surgical approach. Angiology 1990;41:1-11.
30. Palumbo PJ, O'Fallon WM, Osmundson PJ, Zimmermann BR, Langworthy AL, Kazmier FJ. Progression of peripheral occlusive arterial disease in diabetes mellitus. What factors are predictive? Arch Intern Med 1991;151:717-721.
31. Donnelly R, Yeung JM. Management of intermittent claudication: the importance of secondary prevention. Eur J Vasc Endovasc Surg 2002;23:100-107.
32. Dormandy J, Heeck L, Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg 1999;12:123-137.
33. Cimminiello C. PAD. Epidemiology and pathophysiology. Thromb Res 2002;106:295-301.
34. Cassar K, Bachoo P, Brittenden J. The effect of peripheral percutaneous transluminal angioplasty on quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2003;26:130-136.
35. Taft C, Karlsson J, Gelin J, Jivegard L, Sandström R, Arfvidsson B, Dahllöf AG, Lundholm K, Sullivan M. Treatment efficacy of intermittent claudication by invasive therapy, supervised physical exercise training compared to no treatment in unselected randomised patients II: One-year results of health-related quality of life. Eur J Vasc Endovasc Surg 2001;22: 114-123.